PTC制药 PTCT
$65.44 −$0.23 (-0.35%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $65.39 -0.08%
开盘$65.99
昨收$65.67
当日区间$65.15 – $66.67
成交量899.0K
市值$5.47B
市盈率（TTM）–
股息率–
财报
财报日平均波动±8.4%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+14.3%
最差反应-22.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 29 Oct 2026 | After Market | ±14.1% | -6.97% | 符合区间 |
| 2026/Q2 | 30 Jul 2026 | After Market | ±10.6% | -9.94% | 符合区间 |
| 2026/Q1 | 7 May 2026 | After Market | ±9.3% | +14.27% | 超出定价预期 |
| 2025/Q4 | 19 Feb 2026 | After Market | ±8.6% | +1.09% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±11.3% | +5.98% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±11.3% | -9.89% | 符合区间 |
| 2025/Q1 | 6 May 2025 | After Market | ±12.4% | +12.63% | 超出定价预期 |
| 2024/Q4 | 27 Feb 2025 | After Market | ±20.2% | +9.27% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±9.4% | +3.07% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±13.8% | -3.57% | 符合区间 |
| 2024/Q1 | 25 Apr 2024 | After Market | ±20.3% | +12.08% | 符合区间 |
| 2023/Q4 | 29 Feb 2024 | After Market | ±18.2% | +13.34% | 符合区间 |
| 2023/Q3 | 26 Oct 2023 | After Market | ±12.8% | -22.71% | 超出定价预期 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±11.9% | -3.99% | 符合区间 |
| 2023/Q1 | 27 Apr 2023 | After Market | ±12.8% | +4.75% | 符合区间 |
| 2022/Q4 | 21 Feb 2023 | After Market | ±15.7% | -1.10% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q3, ended Sep 2026
营收$357.81M+69.6% YoY
营业利润$25.11M+620.0% YoY
净利润-$51.69M-425.2% YoY
摊薄每股收益-$0.62-410.0% YoY
自由现金流-$31.33M+90.3% YoY
经营现金流-$25.31M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率93.2%
营业利润率12.0%
净利率-9.2%
资产收益率-3.6%
流动比率3.27
负债/资产比率106.0%
现金及投资$2.13B
总负债$621.82M
净现金（净负债）$1.51B
暂无评论——快来第一个聊聊 PTCT。
登录后参与讨论。